Danaher R&D decreased by 11.6% to $387.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $379.00M to $387.00M. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a 1.6% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $426.00M | $441.00M | $251.00M | $441.00M | $431.00M | $420.00M | $236.00M | $373.00M | $361.00M | $362.00M | $407.00M | $368.00M | $391.00M | $383.00M | $442.00M | $379.00M | $403.00M | $378.00M | $438.00M | $387.00M |
| QoQ Change | — | +3.5% | -43.1% | +75.7% | -2.3% | -2.6% | -43.8% | +58.1% | -3.2% | +0.3% | +12.4% | -9.6% | +6.3% | -2.0% | +15.4% | -14.3% | +6.3% | -6.2% | +15.9% | -11.6% |
| YoY Change | — | — | — | — | +1.2% | -4.8% | -6.0% | -15.4% | -16.2% | -13.8% | +72.5% | -1.3% | +8.3% | +5.8% | +8.6% | +3.0% | +3.1% | -1.3% | -0.9% | +2.1% |
Range$236.00M – $442.00M
CAGR-2.0%
Avg YoY Growth+2.8%
Median YoY Growth+0.1%
R&D at Other Companies
Frequently Asked Questions
- What is Danaher's r&d?
- Danaher (DHR) reported r&d of $387.00M in Q1 2026.
- How has Danaher's r&d changed year-over-year?
- Danaher's r&d increased by 2.1% year-over-year, from $379.00M to $387.00M.
- What is the long-term trend for Danaher's r&d?
- Over 4 years (2021 to 2025), Danaher's r&d has grown at a 1.6% compound annual growth rate (CAGR), from $1.50B to $1.60B.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.